Protection of Specific-pathogen-free (Spf) Foals from Severe Equine Herpesvirus Type-1 (Ehv-1) Infection Following Immunization with Non-infectious L-particles

  • Mohd Lila Mohd-Azmi (Faculty of Veterinary Medicine, University Putra Malaysia) ;
  • John Gibson (Centre for Clinical Veterinary Medicine, University of Cambridge, Madingley Road) ;
  • Frazer Rixon (Institute of Virology, Hill Street Road, Glasgow, U.K.) ;
  • Lauchlan, John-Mc (Institute of Virology, Hill Street Road, Glasgow, U.K.) ;
  • Field, Hugh-John (Faculty of Veterinary Medicine, University Putra Malaysia)
  • Published : 2002.09.01

Abstract

Cells infected With equine herpesvirus type-1 (EHV-1) Produced both infectious and non-infectious Virus-related particles. Compared to the whole virion, non-infectious particles termed L-particles were deter-mined to lack 150 kDa protein, commonly known as nucleocapsid protein. The potential of L-particles to induce immune responses was studied in mice and foals. Intranasal immunization with L-particles or whole virions induced poor IgG antibody responses in mice. Interestingly, despite the poor antibody response, the conferred immunity protected the host from challenge infections. This was indicated by a significant reduction in virus titers in line with recovery towards normal body weight. Subsequently, the test on the usefulness of L-particles as immunizing agents was extended to foals. Immunization of specific-pathogen-free (SPF) foals resulted in similar results. As determined by a complement-fixing-antibody test (CFT), foals seroconverted when they were immunized either with inactivated L-particles or whole virions via intramuscular (i.m.) injections. The presence of the antibody correlated with the degree of protection. Beyond day 1 post challenge infection (p.i.), there was no virus shedding in the nasal mucus of foals immunized with whole EHV-1 virions. Virus shedding was observed in foals Immunized with L-particles but limited to days 6 to 8 p.i. only. In contrast, extended vim shedding was observed in non-immunized foals and it was well beyond day 14 p.i. Viremia was not detected for more than four days except in non-immunized foals. Immunization in mice via intranasal (i.n.) conferred good protection. However, compared to the i.n. route, a greater degree of protection was obtained in foals following immunization via i.m. route. Despite variation in the degree of protection due to different routes of immunization in the two animal species, our results have established significant evidence that immunization with L-particles confers protection in the natural host. It is suggested that non-infectious L-particles should be used as immunizing agents for vaccination of horses against EHV-1 infection.

Keywords

References

  1. J. Immunol v.144 Purification and characterization of intraparenchymal lung lymphocytes Abraham, E;A. A. Freitas;A. A. Coutinho
  2. Vaccine v.19 Solid matrixantibody-antigen complexes incorporating equine herpesvirus I glycoproteins C and D elicit anti-viral immune responses in BALB/c(H-2k(d))and C3H(H-2K(k)) mice Alber, D. G;R. A. Killington;A. Stokes
  3. J. Gen. Virol v.74 Cell-mediated antiviral response to EHV-1 in a murine model by means of adoptive transfer of immune spleen cells Azmi, M;H. J. Field
  4. J. Vet. Malaysia v.7 Class and subclass of antibody responses to equine herpesvirus type-1(EHV-1) in the serum and respiratory secretions of infected-mice Azmi, M
  5. Virus Res v.40 Molecular studies of the acute infection, latency and reactivation of equine herpesvirus-1 (EHV-1) in the mouse model Baxi, M. K;K. Borchers;T. Bartels;A. Schellenbach;S. Baxi;H. J. Field
  6. Arch. Virol v.145 Prevalence of equine herpesvirus type 1 latency detected by polymerase chain reacton Carvalho, R;A. M. Oliveira;A. M. Souza;L. M. Passos;A. S. Martins
  7. Immunology v.90 Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse Charan, S. K;Palmer, P. Chester;A. R. Mire-Sluis;A. Meager;N. Edington
  8. Arch. Virol v.145 EHV-1 glycoprotein D(EHV-1 gD)is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice Csellner, H;C. Walker;J. E. Wellington;L. E. McLure;D. N. Love;J. M. Whalley
  9. Virology v.239 The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus Dargan, D. J;J. H. Subak-Sharpe
  10. J. Comp. ㅖㅁ쇄ㅣ v.123 A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes Ferrari, M;T. C. Mettenleiter;M. G. Romanelli;E. Cabassi;A. Corradi;N. Dal Mas;R. Silini
  11. Arch. Virol v.123 Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals:primary and secondary infections and reactivation Gibson, J. S;J. D. Slater;A. R. Awan;H. J. Field
  12. J. Birol v.75 Egress of alphaherpesviruses: comparative ultrastructural studt Granzow, H;B. G. Klupp;W. Fuchs;J. Veits;N. Osterrieder;T. C. Mettenleiter
  13. Res. Vet. Sci v.54 Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain Hannant, D;D. M. Jessett;T. O'Neill;C. A. Dolby;R. F. Cook;J. A. Mumford
  14. J. Virol v.67 Characterization of the myristylated polypeptide encoded by the UL1 gene that is conserved in the genome of defective interfering particles of equine herpesvirus 1 Harty, R. N;G. B. Caughman;V. R. Holden;D. J. O'Callaghan
  15. Am. J. Vet. Res v.19 Serological studies with the virus of vesicular stomatitis. I. Typing of vesicular stomatitis by complement fixation Jenny, E. W;L. O. Mott;E. Traub
  16. Vet. Microbiol v.62 Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion Kukreja, a;C. Walker;T. Fitzmaurice;A. R. Awan;D. N. Love;J. M. Whalley;H. J. Field
  17. Nature v.227 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Laemmli, U. K
  18. J. Gen. Virol v.73 Characterization of enveloped tegument structures (L paarticles) produced by alphaherpesviruses: integrity of the tegument does not depend on the presence of capside or envelope McLauchlan, J;F. J. Rixon
  19. Virology v.190 Noninfectious L-particles supply functions which can facilitate infection by HSV-1 McLauchlan, J;C. addison;M. C. Craigie;F. J. Rixon
  20. J. Gen. Virol v.75 The herpes simplex virus type 1 UL37 gene product is a component of virus particles McLauchlan, J;K. Liefkens;N. D. Stow
  21. Avian Pathol v.11 Enzyme-linked immunosorbent assay (ELISA)for detecting infectious laryngotracheitis viral antibodies in chicken serum Meulemans, G;P. Halen
  22. J. Microbiol v.40 Protective immune responses induced by non-infectious L-particles of Equine Herpesvirus Type-1: Implication of cellular immunity Mohd-Azmi, M. L;H. J. Field;F. Rixon;J. McLauchlan
  23. J. Comp. Pathol v.123 Demonstration of equine herpesvirus-1 gene expression in the placental trophoblasts of naturally aborted equine fetuses Mukaiya, R;T. Kimura;K. Ochiai;R. Wada;T. Umemura
  24. Vet. Microbiol v.16 Characteristics of glycoprotein B of equine herpesvirus 1 expressed by a recombinant baculovirus Munro, K. I;J. E. Wellington;D. N, Love;J. M. Whalley
  25. Virology v.227 Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread Neubauer, A;b. Braun;C. Brandmuller;O. R. Kaaden;N. Osterrieder
  26. Vet. Microbiol v.61 Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1(EHV-1)gB, gC and gD alone or in combinations in BALA/c mice Packiarajah, P;C. Walker;J. Gilkerson;J. M. Whalley;D. N. Love
  27. Equine Vet. J v.31 Clinical, haematological and biochemical findings in foals with neonatal Equine herpesvirus-1 infection compared with septic and premature foals Perkins, G;D. M. Ainsworth;N. H. Erb;Del Piero;M. Miller;P. A. Wilkins;J. Palmer;M. Frazer
  28. J. Gen. Virol v.73 Assembly of enveloped tegument structures (L particles)can occur independently of virion maturation in herpes simplex virus type 1-infected cells Rixon, F. J;C. Addison;J. McLauchlan;J
  29. Vet. Microbiol v.76 Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4antibody Ruitenberg, K. M;D. N. Love;J. R. Gilkerson;J. E. Wellington;J. M Whalley
  30. Virus Res v.46 Two-dimensional gel analysis of [35S] methionine labelled and phosphorylated proteins present in virions and light particles of herpes simplex virus type 1, and detection of potentially structural proteins Sathananthan, B;E. Rodahl;T. Ekberg;N. Langeland;L. Haarr
  31. Virsu Res v.50 High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H(H-2Kk) murine model Stokes, A;R. S. Cameron;R. N. Marshall;R. A. Killington
  32. J. Gen. Virol v.75 Herpes simplex virus L particles contain spherical membrane-enclosed inclusion Szilagyi, J. F;J. Berriman
  33. J. Gen. Virol v.72 Identification and characterisation of a novel non-infectious herpes simplex virusrelated particle Szilagyi, J. F;C. Cunningham
  34. J. Gen. Virol v.75 Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in murine model Tewari, D;J. M. Whalley;D. N. Love;H. J. Field
  35. J. Gen. Virol v.71 Production of interleukin 1 and tumour necrosis factor activities in bronchoalveolar washings following infection of mice by influenza virus Vacheron F;A. Rudent;S. Perin;C. Labarre;A. M. Quero;M. Guenounou
  36. Vet. Microbiol v.76 Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion Walker, C;K. M. Ruitenberg;D. N. Love;J. M. Whalley
  37. Virology v.211 Influence of the host cell on the association of ICP4 and ICP0 with herpes simplex virus type 1 Yang, T. Y;R. J. Courtney